<bill session="112" type="sr" number="499" updated="2012-11-24T15:03:31-05:00">
	<state datetime="2012-06-19">PASSED:SIMPLERES</state>
	<status><vote datetime="2012-06-19" where="s" result="pass" how="by Unanimous Consent" roll=""/></status>

	<introduced datetime="2012-06-19"/>
	<titles>
		<title type="official" as="introduced">A resolution recognizing the tenth anniversary of the National Institute of Biomedical Imaging and Bioengineering.</title>
	</titles>
	<sponsor id="400054"/>
	<cosponsors>
		<cosponsor id="300073" joined="2012-06-19"/>
	</cosponsors>
	<actions>
		<vote how="by Unanimous Consent" type="vote" datetime="2012-06-19" where="s" result="pass"  state="PASSED:SIMPLERES"><text>Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.</text><reference label="consideration" ref="CR S4308-4310"/><reference label="text as passed Senate" ref="CR S4310"/><reference label="text of measure as introduced" ref="CR S4305"/></vote>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Health"/>
		<term name="Congressional tributes"/>
		<term name="Department of Health and Human Services"/>
		<term name="Health technology, devices, supplies"/>
		<term name="Medical research"/>
		<term name="National Institutes of Health (NIH)"/>
		<term name="Research administration and funding"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	6/19/2012--Passed Senate without amendment. (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Commends the National Institute of Biomedical Imaging and Bioengineering for its leadership in research and its role in advancing technologies that improve patient health. Recognizes: (1) the remarkable impact that biomedical research supported by the Institute has had on patients, and (2) the importance of maintaining a strong commitment to pursuing the next generation of life-saving treatments and technologies.

	</summary>
</bill>
